ISMP Issues Warning about Possible Safety Issues with Newly Authorized Antiviral
News item covers ISMP’s alert regarding Paxlovid for treatment of COVID-19, highlighting that a dose reduction is necessary for patients with moderate renal impairment.
For the full text, visit APhA online.